Skip to main content
Top
Published in: Annals of Hematology 3/2014

01-03-2014 | Original Article

Novel genetic abnormalities in Bernard-Soulier syndrome in India

Authors: Shahnaz Ali, Kanjaksha Ghosh, Shrimati Shetty

Published in: Annals of Hematology | Issue 3/2014

Login to get access

Abstract

Bernard-Soulier syndrome (BSS) is a severe inherited bleeding disorder due to defects in GPIb/IX/V, a platelet receptor that normally functions as a platelet membrane receptor for von Willebrand factor, thrombin and factor XI. BSS results from mutations in GP1BA, GP1BB or GP9 genes. In 15 patients with Bernard-Soulier syndrome from Western India, we amplified the entire coding sequences of GP1BA, GP1BB and GP9 genes and directly sequenced them. Twelve homozygous changes have been identified, out of which ten were novel mutations. These included eight frameshift mutations, i.e. p.Asp79GlufsX2, p.Phe314PhefsX37, p.Pro93ProfsX59, p.Asp89GlufsX63, p.Glu489AsnfsX64, p.Phe355PhefsX4, p.Leu479PhefsX19 and p.Leu531ArgfsX22, one missense mutation (p.Val262Gly) in GPIBA and one nonsense mutation (p.Tyr95X) in GP9. The two known changes include one missense mutation (p.Cys24Arg) in GP9 and one nonsense change (p.Trp46X) in GPIBB. A wide heterogeneity in the nature of mutations has been observed in Indian BSS patients in the present study. Identification of mutations in this rare platelet function disorder would pave way for genetic diagnosis in affected families in India, where consanguineous marriages are very common.
Literature
1.
go back to reference Dong JF, Gao S, Lopez JA (1998) Synthesis, assembly, and intracellular transport of the platelet glycoprotein Ib-IX-V complex. J Biol Chem 273:31449–31454CrossRefPubMed Dong JF, Gao S, Lopez JA (1998) Synthesis, assembly, and intracellular transport of the platelet glycoprotein Ib-IX-V complex. J Biol Chem 273:31449–31454CrossRefPubMed
2.
go back to reference Noris P, Perrotta S, Bottega R et al (2012) Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation). Haematologica 97:82–88CrossRefPubMed Noris P, Perrotta S, Bottega R et al (2012) Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation). Haematologica 97:82–88CrossRefPubMed
3.
go back to reference Pham A, Wang J (2007) Bernard-Soulier syndrome: an inherited platelet disorder. Archives of Pathol Lab Med 131:1834–1836 Pham A, Wang J (2007) Bernard-Soulier syndrome: an inherited platelet disorder. Archives of Pathol Lab Med 131:1834–1836
6.
go back to reference Savoia A, Pastore A, De Rocco D et al (2011) Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. Haematologica 96:417–423CrossRefPubMed Savoia A, Pastore A, De Rocco D et al (2011) Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. Haematologica 96:417–423CrossRefPubMed
7.
go back to reference Kunishima S, Lopez JA, Kobayashi S et al (1997) Missense mutations of the glycoprotein (GP) Ib beta gene impairing the GPIb alpha/beta disulfide linkage in a family with giant platelet disorder. Blood 89:2404–2412PubMed Kunishima S, Lopez JA, Kobayashi S et al (1997) Missense mutations of the glycoprotein (GP) Ib beta gene impairing the GPIb alpha/beta disulfide linkage in a family with giant platelet disorder. Blood 89:2404–2412PubMed
8.
9.
go back to reference Thusberg J, Olatubosun A, Vihinen M (2011) Performance of mutation pathogenicity prediction methods on missense variants. Hum Mutat 32:358–368CrossRefPubMed Thusberg J, Olatubosun A, Vihinen M (2011) Performance of mutation pathogenicity prediction methods on missense variants. Hum Mutat 32:358–368CrossRefPubMed
10.
go back to reference Mathe E, Olivier M, Kato S, Ishioka C, Hainaut P, Tavtigian SV (2006) Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Research 34:1317–1322CrossRefPubMedCentralPubMed Mathe E, Olivier M, Kato S, Ishioka C, Hainaut P, Tavtigian SV (2006) Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Research 34:1317–1322CrossRefPubMedCentralPubMed
11.
go back to reference Rivera CE, Villagra J, Riordan M, Williams S, Lindstrom KJ, Rick ME (2001) Identification of a new mutation in platelet glycoprotein IX (GPIX) in a patient with Bernard-Soulier syndrome. Br J Haematol 112:105–108CrossRefPubMed Rivera CE, Villagra J, Riordan M, Williams S, Lindstrom KJ, Rick ME (2001) Identification of a new mutation in platelet glycoprotein IX (GPIX) in a patient with Bernard-Soulier syndrome. Br J Haematol 112:105–108CrossRefPubMed
12.
go back to reference Moran N, Morateck PA, Deering A et al (2000) Surface expression of glycoprotein Ib alpha is dependent on glycoprotein Ib beta: evidence from a novel mutation causing Bernard-Soulier syndrome. Blood 96:532–539PubMed Moran N, Morateck PA, Deering A et al (2000) Surface expression of glycoprotein Ib alpha is dependent on glycoprotein Ib beta: evidence from a novel mutation causing Bernard-Soulier syndrome. Blood 96:532–539PubMed
Metadata
Title
Novel genetic abnormalities in Bernard-Soulier syndrome in India
Authors
Shahnaz Ali
Kanjaksha Ghosh
Shrimati Shetty
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1895-x

Other articles of this Issue 3/2014

Annals of Hematology 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine